Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.

Rogliani P, Bakakos P, Stolz D, Piraino A, Franzini L, Nudo E, Di Palma L, Brusselle G

Open source

DOI
10.2147/copd.s603262
Published
2026
Container
International journal of chronic obstructive pulmonary disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/copd.s603262,
  title = {Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.},
  author = {Rogliani P and Bakakos P and Stolz D and Piraino A and Franzini L and Nudo E and Di Palma L and Brusselle G},
  year = {2026},
  journal = {International journal of chronic obstructive pulmonary disease},
  doi = {10.2147/copd.s603262},
  url = {https://doi.org/10.2147/copd.s603262}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.
AU  - Rogliani P
AU  - Bakakos P
AU  - Stolz D
AU  - Piraino A
AU  - Franzini L
AU  - Nudo E
AU  - Di Palma L
AU  - Brusselle G
PY  - 2026
JO  - International journal of chronic obstructive pulmonary disease
DO  - 10.2147/copd.s603262
UR  - https://doi.org/10.2147/copd.s603262
ER  - 

APA

P, R., P, B., D, S., A, P., L, F., E, N., L, D. P., & G, B. (2026). Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.. International journal of chronic obstructive pulmonary disease. https://doi.org/10.2147/copd.s603262

Source records